to take something away from forcibly; dispossess: to deprive someone of his property; to keep from having, using, or enjoying: to be deprived of one's rights; to remove from office, esp. ecclesiastical office; Origin of deprive
Shares of Haemonetics Corporation HAE scaled a new 52-week high of $58.02 on Nov 17, closing nominally lower at $57.99. The company has gained 43.9% in the last six months, much higher than the S&P 500âs gain of 7.8%. Haemonetics has also beat the broader industryâs gain of 7.3%. The stock has a market cap of $3.06 billion. Further, Haemoneticsâ estimate revision trend for the current year is favorable. In the past 30 days, five estimates moved up with no movement in the opposite direction. Consequently, estimates were up from $1.61 per share to $1.70.
Oracle has indeed made another acquisition: marketing tech startup BlueKai. UPDATED: The company did not announce terms for the deal but a source tells us the purchase price was around $400 million. BlueKai offers a cloud service that allows marketeers to understand who people are as they surf the web. That lets them find the right people to send their ads and offers to.